Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nociceptin receptor | ||
Ligand | BDBM50100988 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1452449 (CHEMBL3362473) | ||
Ki | 290±n/a nM | ||
Citation | Schunk, S; Linz, K; Frormann, S; Hinze, C; Oberbörsch, S; Sundermann, B; Zemolka, S; Englberger, W; Germann, T; Christoph, T; Kögel, BY; Schröder, W; Harlfinger, S; Saunders, D; Kless, A; Schick, H; Sonnenschein, H Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists. ACS Med Chem Lett5:851-6 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Nociceptin receptor | |||
Name: | Nociceptin receptor | ||
Synonyms: | KOR-3 | Kappa-type 3 opioid receptor | Mu-type opioid receptor (Mu) | NOP | Nociceptin Receptor (ORL1 Receptor) | Nociceptin receptor (NOP) | Nociceptin receptor (ORL-1) | Nociceptin receptor (ORL1) | Nociceptin/Orphanin FQ, NOP receptor | OOR | OPIATE ORL-1 | OPRL1 | OPRL1 protein | OPRX_HUMAN | ORL1 | ORL1 receptor | Opioid receptor like-1 | Orphanin FQ receptor | Orphanin FQ receptor (ORL1) | P41146 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 40702.87 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P41146 | ||
Residue: | 370 | ||
Sequence: |
| ||
BDBM50100988 | |||
n/a | |||
Name | BDBM50100988 | ||
Synonyms: | CHEMBL3325749 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H28ClNO | ||
Mol. Mass. | 345.906 | ||
SMILES | Cl.CN(C)[C@@]1(CC[C@@H](CC1)OCc1ccccc1)c1ccccc1 |r,wU:7.9,4.2,(41.96,-10.01,;38.57,-8.8,;37.23,-8.03,;37.23,-6.49,;35.9,-8.81,;35.12,-7.48,;33.58,-7.48,;32.82,-8.82,;33.59,-10.14,;35.13,-10.14,;31.27,-8.79,;30.49,-10.11,;28.95,-10.09,;28.2,-8.74,;26.66,-8.72,;25.87,-10.05,;26.63,-11.4,;28.17,-11.41,;36.69,-10.13,;35.95,-11.47,;36.74,-12.79,;38.29,-12.76,;39.03,-11.4,;38.23,-10.09,)| | ||
Structure |